HemaCare BioScience engages in the research and development of in vitro diagnostic, pharmaceutical, and biotechnology products. It offers clinical trial management services, biological materials, quality control products, laboratory testing and other solutions that enable product development and research in infectious diseases, such as oncology, rheumatology, endocrinology, cardiology, and genetic disorders. The company was founded in 1998 and is headquartered in Fort Lauderdale, Florida.